258 related articles for article (PubMed ID: 10458598)
1. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization.
Cohen Z; Bouchelet I; Olivier A; Villemure JG; Ball R; Stanimirovic DB; Hamel E
J Cereb Blood Flow Metab; 1999 Aug; 19(8):908-17. PubMed ID: 10458598
[TBL] [Abstract][Full Text] [Related]
2. Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular localization.
Elhusseiny A; Cohen Z; Olivier A; Stanimirović DB; Hamel E
J Cereb Blood Flow Metab; 1999 Jul; 19(7):794-802. PubMed ID: 10413035
[TBL] [Abstract][Full Text] [Related]
3. Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture.
Abounader R; Elhusseiny A; Cohen Z; Olivier A; Stanimirovic D; Quirion R; Hamel E
J Cereb Blood Flow Metab; 1999 Feb; 19(2):155-63. PubMed ID: 10027771
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels.
Bouchelet I; Cohen Z; Case B; Séguéla P; Hamel E
Mol Pharmacol; 1996 Aug; 50(2):219-23. PubMed ID: 8700126
[TBL] [Abstract][Full Text] [Related]
5. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
6. Functional calcitonin gene-related peptide type 1 and adrenomedullin receptors in human trigeminal ganglia, brain vessels, and cerebromicrovascular or astroglial cells in culture.
Moreno MJ; Cohen Z; Stanimirovic DB; Hamel E
J Cereb Blood Flow Metab; 1999 Nov; 19(11):1270-8. PubMed ID: 10566974
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression.
Verheggen R; Hundeshagen AG; Brown AM; Schindler M; Kaumann AJ
Br J Pharmacol; 1998 Aug; 124(7):1345-54. PubMed ID: 9723944
[TBL] [Abstract][Full Text] [Related]
8. Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries.
Hamel E; Fan E; Linville D; Ting V; Villemure JG; Chia LS
Mol Pharmacol; 1993 Aug; 44(2):242-6. PubMed ID: 8394988
[TBL] [Abstract][Full Text] [Related]
9. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
[TBL] [Abstract][Full Text] [Related]
10. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
11. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
Bouchelet I; Case B; Olivier A; Hamel E
Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348
[TBL] [Abstract][Full Text] [Related]
12. Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes.
Shimizu M; Nishida A; Zensho H; Yamawaki S
J Pharmacol Exp Ther; 1996 Dec; 279(3):1551-8. PubMed ID: 8968382
[TBL] [Abstract][Full Text] [Related]
13. Intracellular cAMP and calcium signaling by serotonin in mouse cumulus-oocyte complexes.
Amireault P; Dubé F
Mol Pharmacol; 2005 Dec; 68(6):1678-87. PubMed ID: 16131615
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of alpha-actin mRNA and immunoreactive protein in brain microvascular pericytes and smooth muscle cells.
Boado RJ; Pardridge WM
J Neurosci Res; 1994 Nov; 39(4):430-5. PubMed ID: 7884822
[TBL] [Abstract][Full Text] [Related]
15. Cultured astrocytes express messenger RNA for multiple serotonin receptor subtypes, without functional coupling of 5-HT1 receptor subtypes to adenylyl cyclase.
Hirst WD; Cheung NY; Rattray M; Price GW; Wilkin GP
Brain Res Mol Brain Res; 1998 Oct; 61(1-2):90-9. PubMed ID: 9795156
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
Adham N; Zgombick JM; Bard J; Branchek TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
[TBL] [Abstract][Full Text] [Related]
17. Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).
Jasper JR; Kosaka A; To ZP; Chang DJ; Eglen RM
Br J Pharmacol; 1997 Sep; 122(1):126-32. PubMed ID: 9298538
[TBL] [Abstract][Full Text] [Related]
18. 5-HT receptors mediating external carotid vasoconstriction in vagosympathectomized dogs.
Villalón CM; Centurión D; Sánchez-López A; De Vries P; Saxena P
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1057-67. PubMed ID: 11216445
[TBL] [Abstract][Full Text] [Related]
19. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
[TBL] [Abstract][Full Text] [Related]
20. Studies on the neuroendocrine role of serotonin.
Jørgensen HS
Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
